0001005286 1 2025-08-07 2025-08-07 0001005286 2025-08-07 2025-08-07 shares iso4217:USD pure 0001005286 LIFECORE BIOMEDICAL, INC. S-8 S-8 EX-FILING FEES N/A Equity false Common Stock, par value $0.001 per share true 750000 7.19 5392500 5392500 0.0001531 825.59 825.59 0 825.59 <span style="color:#0d0d0d;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.18pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the registration statement on Form S-8 shall also cover any additional shares of the common stock of Lifecore Biomedical, Inc. (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant’s common stock.</span><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:112%">(2)</span><span style="color:#0d0d0d;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:5.18pt">Represents 750,000 shares of the Registrant’s common stock reserved under the Registrant’s Equity Inducement Plan adopted on March 20, 2024, as amended by a First Amendment dated April 11, 2025.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(3)</span><span style="color:#0d0d0d;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.18pt">Estimated solely for the purpose of calculating the registration fee and computed in accordance with Rule 457(c) and (h) under the Securities Act using the average of the high and low sale prices of the common stock on </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">August 4, 2025</span><span style="color:#0d0d0d;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, as reported on The Nasdaq Global Select Market.</span></div>